Interventional neurology devices market seen reaching $3.72 billion by 2030

The Business Research Company says the interventional neurology devices and equipment market will grow from $2.64 billion in 2026 to $3.72 billion by 2030, driven by stroke care demand, minimally invasive treatment adoption and AI-enabled neuroimaging. North America held the largest share in 2025, while Asia-Pacific ranked second.

Why it matters: - The market is tied to treatment for stroke, brain aneurysms and other neurological disorders, so growth points to rising demand for faster, less invasive care. - The report highlights opportunities for device makers as hospitals expand comprehensive stroke centers and adopt more advanced neurovascular tools.

What happened: - The Business Research Company published a report on the global interventional neurology devices and equipment market on August 12, 2026. - The market is projected to rise from $2.45 billion in 2025 to $2.64 billion in 2026. - The report forecasts the market will reach $3.72 billion by 2030. - North America held the largest regional share in 2025. - Asia-Pacific was the second-largest regional market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

The details: - Interventional neurology devices include stents, catheters, coils and related tools used in minimally invasive neurological procedures. - The devices are used to treat conditions including brain aneurysms, strokes and spinal disorders. - The 2025-2026 growth rate is 7.6%. - The 2026-2030 forecast implies a 9.0% CAGR. - Historical growth has been linked to higher stroke and cerebral aneurysm prevalence, more specialized neurology centers, wider awareness of endovascular treatment, microcatheter improvements and better imaging. - Future growth is expected to be driven by demand for stroke management solutions, AI-enhanced neuroimaging, expansion of comprehensive stroke centers, early intervention strategies and investment in neurovascular technology. - Key trends expected in the market include more neurothrombectomy devices, broader use of flow diversion and embolization, more image-guided neurointerventions, wider adoption of minimally invasive stroke therapies and faster intervention timelines. - The report says the market is also being supported by the growing incidence of neurological disorders worldwide. - The report cites around 6 million people in the U.S. living with unruptured brain aneurysms, more than 50 million people globally with epilepsy and more than 47 million with dementia. - The report also points to the increasing preference for minimally invasive procedures as a demand driver. - ISAPS reported in June 2024 that total surgical and non-surgical procedures rose 3.4% to 34.9 million in 2023. - ISAPS said surgical procedures rose 5.5%, with more than 15.8 million surgical interventions and 19.1 million non-surgical treatments.

Between the lines: - The forecast suggests the market is moving from broad demand for neurovascular care toward a technology race focused on speed, precision and imaging. - North America’s lead likely reflects deeper specialty infrastructure, while Asia-Pacific’s position signals room for faster expansion as care capacity grows. - The report’s inclusion of TAM analysis, company scoring and forecasting dashboards suggests the market is being positioned for more active competitive tracking.

What's next: - The market is expected to keep expanding through 2030 as hospitals adopt minimally invasive and image-guided neurointerventions. - More use of AI in neuroimaging and broader stroke-center coverage should continue shaping product demand. - The report points to continued interest in neurothrombectomy, flow diversion and embolization devices as core growth areas. - The Business Research Company is offering the report’s sample and full version online via a free sample and the full report.

The bottom line: - Interventional neurology is moving toward faster, less invasive treatment models, and the market outlook points to sustained growth as hospitals and device makers invest in that shift.